Incyte (INCY) Misses Q4 EPS by 8c
Tweet
Share
E-mail
Get Alerts INCY Hot Sheet
Price: $124.97 -1.4%
EPS Growth %: -225.2%
Financial Fact:
Contract revenues: 3.21M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -225.2%
Financial Fact:
Contract revenues: 3.21M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q4 EPS of $0.05, $0.08 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $326 million versus the consensus estimate of $324.42 million.
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
- JPMorgan starts FedEx Freight at Overweight on post-spin turnaround
- Chime to acquire Stride Bank for $590M in cash
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
